Clinical Trial Update: Pilot Study of Radiation-Enhanced Allogeneic Cell Therapy for Progressive Hematologic Malignancy After Allogeneic Hematopoietic Stem Cell Transplantation [Phase 2]

View source ↗

Summary

Phase 2 pilot trial evaluating radiation-enhanced allogeneic cell therapy for progressive hematologic malignancies after allogeneic stem cell transplantation; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Hodgkin Lymphoma
• Multiple Myeloma with Plasmacytoma
• Non-hodgkin Lymphoma

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma | Phase 2 | Status: TERMINATED | Results posted: 2015-09-07